| 标题 |
Abstract A118: Daraxonrasib, a RAS(ON) multi-selective inhibitor, exhibits potent antitumor activity and combinatorial benefit with standard of care chemotherapy and with anti-PD-1 in preclinical models of KRAS G12R PDAC |
| 备注 |
请求原始poster文件
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI |
10.1158/1538-7445.pancreatic25-a118
doi
|
| 其它 |
期刊:Cancer Research 作者:Urszula N. Wasko-Kornberg; Jasmine Y. Lee; Xing Wei; Yongxian Zhuang; Enrico Payson; et al 出版日期:2025-09-28 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)